Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
1.
Purinergic Signal ; 12(2): 313-29, 2016 06.
Artículo en Inglés | MEDLINE | ID: mdl-26969588

RESUMEN

The G protein-coupled A2A adenosine receptor represents an important drug target. Crystal structures and modeling studies indicated that three disulfide bonds are formed between ECL1 and ECL2 (I, Cys71(2.69)-Cys159(45.43); II, Cys74(3.22)-Cys146(45.30), and III, Cys77(3.25)-Cys166(45.50)). However, the A2BAR subtype appears to require only disulfide bond III for proper function. In this study, each of the three disulfide bonds in the A2AAR was disrupted by mutation of one of the cysteine residues to serine. The mutant receptors were stably expressed in Chinese hamster ovary cells and analyzed in cyclic adenosine monophosphate (cAMP) accumulation and radioligand binding studies using structurally diverse agonists: adenosine, NECA, CGS21680, and PSB-15826. Results were rationalized by molecular modeling. The observed effects were dependent on the investigated agonist. Loss of disulfide bond I led to a widening of the orthosteric binding pocket resulting in a strong reduction in the potency of adenosine, but not of NECA or 2-substituted nucleosides. Disruption of disulfide bond II led to a significant reduction in the agonists' efficacy indicating its importance for receptor activation. Disulfide bond III disruption reduced potency and affinity of the small adenosine agonists and NECA, but not of the larger 2-substituted agonists. While all the three disulfide bonds were essential for high potency or efficacy of adenosine, structural modification of the nucleoside could rescue affinity or efficacy at the mutant receptors. At present, it cannot be excluded that formation of the extracellular disulfide bonds in the A2AAR is dynamic. This might add another level of G protein-coupled receptor (GPCR) modulation, in particular for the cysteine-rich A2A and A2BARs.


Asunto(s)
Cisteína/química , Modelos Moleculares , Receptor de Adenosina A2A/química , Receptor de Adenosina A2A/metabolismo , Animales , Células CHO , Cricetulus , Cisteína/metabolismo , Espacio Extracelular/química , Espacio Extracelular/metabolismo , Humanos , Simulación del Acoplamiento Molecular , Mutagénesis Sitio-Dirigida
2.
Sci Adv ; 7(41): eabi9551, 2021 Oct 08.
Artículo en Inglés | MEDLINE | ID: mdl-34623918

RESUMEN

High-intensity interval training (HIIT) improves cardiorespiratory fitness (VO2max), but its impact on metabolism remains unclear. We hypothesized that 12-week HIIT increases insulin sensitivity in males with or without type 2 diabetes [T2D and NDM (nondiabetic humans)]. However, despite identically higher VO2max, mainly insulin-resistant (IR) persons (T2D and IR NDM) showed distinct alterations of circulating small extracellular vesicles (SEVs) along with lower inhibitory metabolic (protein kinase Cε activity) or inflammatory (nuclear factor κB) signaling in muscle of T2D or IR NDM, respectively. This is related to the specific alterations in SEV proteome reflecting down-regulation of the phospholipase C pathway (T2D) and up-regulated antioxidant capacity (IR NDM). Thus, SEV cargo may contribute to modulating the individual metabolic responsiveness to exercise training in humans.

3.
J Med Chem ; 63(5): 2391-2410, 2020 03 12.
Artículo en Inglés | MEDLINE | ID: mdl-31721581

RESUMEN

The orphan G protein-coupled receptor (GPCR) GPR84 is expressed on immune cells mediating proinflammatory and immunostimulatory effects. In this study, we prepared the fully efficacious, nonbiased GPR84 agonist 6-hexylamino-2,4(1H,3H)-pyrimidinedione (6) in tritium-labeled form ([3H]PSB-1584) by hydrogenation of a hexenyl-substituted precursor with tritium gas. The radioligand was characterized by kinetic, saturation, and competition assays using membranes of Chinese hamster ovary cells recombinantly expressing the human GPR84. [3H]6 reversibly labeled the receptor with high affinity (KD 2.08 nM). Structurally diverse orthosteric and allosteric ligands, including newly designed and synthesized compounds, were studied in competition binding assays. A homology model of GPR84 was generated to perform docking studies rationalizing the experimental data. The radioligand was additionally used for labeling GPR84 in native cells and tissues. [3H]6 constitutes the first GPR84 agonist radioligand representing a powerful tool for this poorly investigated GPCR, which has potential as a future drug target.


Asunto(s)
Pirimidinonas/química , Pirimidinonas/farmacología , Receptores Acoplados a Proteínas G/agonistas , Animales , Unión Competitiva , Células CHO , Cricetulus , Humanos , Modelos Moleculares , Simulación del Acoplamiento Molecular , Ensayo de Unión Radioligante , Receptores Acoplados a Proteínas G/química , Tritio/química , Tritio/farmacología
4.
Biochem Pharmacol ; 172: 113718, 2020 02.
Artículo en Inglés | MEDLINE | ID: mdl-31751537

RESUMEN

A2A and A2B adenosine receptors (ARs) are closely related G protein-coupled receptor subtypes, which represent important (potential) drug targets. Despite their almost identical binding sites for adenosine, A2AARs are activated by low (nanomolar) adenosine concentrations, while A2BARs require micromolar concentrations. In the present study, we exchanged the extracellular loop 2 (ECL2) of the human A2AAR for that of the A2BAR. The resulting chimeric A2A(ECL2-A2B)AR was investigated in radioligand binding and cAMP accumulation assays in comparison to the wildtype A2AAR. While the ribose-modified adenosine analog N-ethylcarboxamidoadenosine (NECA) and its 2-substituted derivative CGS-21680 did not exhibit significant changes, adenosine showed dramatically reduced potency and affinity for the A2A(ECL2-A2B)AR mutant displaying similarly low potency as for the wt A2BAR. Supervised molecular dynamics simulation studies predicted a meta-binding site with high affinity for adenosine, but not for NECA, which may contribute to the observed effects.


Asunto(s)
Adenosina/metabolismo , Furanos/metabolismo , Piperazinas/metabolismo , Purinas/metabolismo , Receptor de Adenosina A2A/metabolismo , Receptor de Adenosina A2B/metabolismo , Adenosina/análogos & derivados , Adenosina/química , Adenosina/farmacología , Animales , Sitios de Unión , Línea Celular , Furanos/química , Furanos/farmacología , Regulación de la Expresión Génica/efectos de los fármacos , Humanos , Modelos Moleculares , Simulación de Dinámica Molecular , Estructura Molecular , Mutación , Fenetilaminas/química , Fenetilaminas/farmacología , Piperazinas/química , Piperazinas/farmacología , Unión Proteica , Conformación Proteica , Agonistas del Receptor Purinérgico P1/química , Agonistas del Receptor Purinérgico P1/farmacología , Purinas/química , Purinas/farmacología , Receptor de Adenosina A2A/química , Receptor de Adenosina A2B/química
5.
Biochim Biophys Acta Proteins Proteom ; 1867(12): 140172, 2019 12.
Artículo en Inglés | MEDLINE | ID: mdl-30502511

RESUMEN

Adipose tissue is an endocrine organ, secreting various adipokines, either directly or via extracellular vesicles, including exosomes. Exosomes are vesicles of 40-150 nm size that represent a novel concept of biomolecule release. We purified exosomes from isolated primary human preadipocytes differentiated to mature adipocytes. The analyses of these exosomal preparations by LC-MS identified 884 proteins, so called exoadipokines. The comparison of exoadipokines with previously identified human exosome-associated proteins in ExoCarta database show an overlap of 817 proteins, but also revealed 67 proteins not assigned to human exosomes, yet. We further compared all exoadipokines to our previously reported reference secretome of human adipose tissue (http://diabesityprot.org/), finding 212 common proteins, whereas 672 proteins were specific for the exosomal fraction. Bioinformatic analyses revealed that the 212 common proteins can be assigned to all major functions of adipose tissue secreted proteins e.g. molecules involved in fibrotic processes or inflammation. In contrast, the exosome-specific proteins were rather assigned to signaling pathways and membrane-mediated processes. In conclusion, the isolation of exosomes allows to further specify the functionality of adipokines and exoadipokines as part of the adipocyte secretome in signaling and interorgan crosstalk.


Asunto(s)
Adipocitos/metabolismo , Tejido Adiposo/metabolismo , Exosomas/metabolismo , Proteoma/metabolismo , Adipoquinas/metabolismo , Células Cultivadas , Femenino , Humanos , Vías Secretoras
6.
Nat Commun ; 10(1): 4179, 2019 09 13.
Artículo en Inglés | MEDLINE | ID: mdl-31519890

RESUMEN

The mechanisms underlying improved insulin sensitivity after surgically-induced weight loss are still unclear. We monitored skeletal muscle metabolism in obese individuals before and over 52 weeks after metabolic surgery. Initial weight loss occurs in parallel with a decrease in muscle oxidative capacity and respiratory control ratio. Persistent elevation of intramyocellular lipid intermediates, likely resulting from unrestrained adipose tissue lipolysis, accompanies the lack of rapid changes in insulin sensitivity. Simultaneously, alterations in skeletal muscle expression of genes involved in calcium/lipid metabolism and mitochondrial function associate with subsequent distinct DNA methylation patterns at 52 weeks after surgery. Thus, initial unfavorable metabolic changes including insulin resistance of adipose tissue and skeletal muscle precede epigenetic modifications of genes involved in muscle energy metabolism and the long-term improvement of insulin sensitivity.


Asunto(s)
Resistencia a la Insulina/fisiología , Músculo Esquelético/metabolismo , Tejido Adiposo/metabolismo , Adulto , Metilación de ADN/genética , Metilación de ADN/fisiología , Epigénesis Genética/genética , Femenino , Derivación Gástrica , Humanos , Resistencia a la Insulina/genética , Metabolismo de los Lípidos/genética , Metabolismo de los Lípidos/fisiología , Masculino , Persona de Mediana Edad , Obesidad/genética , Obesidad/metabolismo , Obesidad/cirugía
7.
Diabetes Care ; 41(6): 1235-1243, 2018 06.
Artículo en Inglés | MEDLINE | ID: mdl-29602794

RESUMEN

OBJECTIVE: Insulin resistance and nonalcoholic fatty liver disease have been linked to several lipid metabolites in animals, but their role in humans remains unclear. This study examined the relationship of sphingolipids with hepatic and peripheral metabolism in 21 insulin-resistant obese patients without (NAFL-) or with (NAFL+) nonalcoholic fatty liver and nonalcoholic steatohepatitis (NASH) and 7 healthy lean individuals undergoing tissue biopsies during bariatric or elective abdominal surgery. RESEARCH DESIGN AND METHODS: Hyperinsulinemic-euglycemic clamps with d-[6,6-2H2]glucose were performed to quantify tissue-specific insulin sensitivity. Hepatic oxidative capacity, lipid peroxidation, and the phosphorylated-to-total c-Jun N-terminal kinase (pJNK-to-tJNK) ratio were measured to assess mitochondrial function, oxidative stress, and inflammatory activity. RESULTS: Hepatic total ceramides were higher by 50% and 33% in NASH compared with NAFL+ and NAFL-, respectively. Only in NASH were hepatic dihydroceramides (16:0, 22:0, and 24:1) and lactosylceramides increased. Serum total ceramides and dihydroceramides (hepatic dihydroceramides 22:0 and 24:1) correlated negatively with whole-body but not with hepatic insulin sensitivity. Hepatic maximal respiration related positively to serum lactosylceramide subspecies, hepatic sphinganine, and lactosylceramide 14:0. Liver lipid peroxides (total ceramides, sphingomyelin 22:0) and the pJNK-to-tJNK ratio (ceramide 24:0; hexosylceramides 22:0, 24:0, and 24:1) all positively correlated with the respective hepatic sphingolipids. CONCLUSIONS: Sphingolipid species are not only increased in insulin-resistant humans with NASH but also correlate with hepatic oxidative stress and inflammation, suggesting that these lipids may play a role during progression of simple steatosis to NASH in humans.


Asunto(s)
Inflamación/metabolismo , Resistencia a la Insulina/fisiología , Hígado/metabolismo , Enfermedad del Hígado Graso no Alcohólico/fisiopatología , Obesidad/fisiopatología , Estrés Oxidativo/fisiología , Esfingolípidos/metabolismo , Adulto , Animales , Progresión de la Enfermedad , Femenino , Técnica de Clampeo de la Glucosa , Humanos , Inflamación/sangre , Inflamación/fisiopatología , Peroxidación de Lípido/fisiología , Hígado/química , Hígado/patología , Masculino , Persona de Mediana Edad , Enfermedad del Hígado Graso no Alcohólico/sangre , Enfermedad del Hígado Graso no Alcohólico/metabolismo , Obesidad/sangre , Obesidad/metabolismo , Obesidad/cirugía , Oxidación-Reducción , Estudios Prospectivos , Esfingolípidos/análisis , Esfingolípidos/sangre
8.
Oncotarget ; 9(17): 13593-13611, 2018 Mar 02.
Artículo en Inglés | MEDLINE | ID: mdl-29568380

RESUMEN

The adenosine receptor (AR) subtypes A2A and A2B are rhodopsin-like Gs protein-coupled receptors whose expression is highly regulated under pathological, e.g. hypoxic, ischemic and inflammatory conditions. Both receptors play important roles in inflammatory and neurodegenerative diseases, are blocked by caffeine, and have now become major drug targets in immuno-oncology. By Förster resonance energy transfer (FRET), bioluminescence resonance energy transfer (BRET), bimolecular fluorescence complementation (BiFC) and proximity ligation assays (PLA) we demonstrated A2A-A2BAR heteromeric complex formation. Moreover we observed a dramatically altered pharmacology of the A2AAR when co-expressed with the A2BAR (A2B ≥ A2A) in recombinant as well as in native cells. In the presence of A2BARs, A2A-selective ligands lost high affinity binding to A2AARs and displayed strongly reduced potency in cAMP accumulation and dynamic mass redistribution (DMR) assays. These results have major implications for the use of A2AAR ligands as drugs as they will fail to modulate the receptor in an A2A-A2B heteromer context. Accordingly, A2A-A2BAR heteromers represent novel pharmacological targets.

9.
Invest Ophthalmol Vis Sci ; 58(7): 3118-3126, 2017 06 01.
Artículo en Inglés | MEDLINE | ID: mdl-28632878

RESUMEN

Purpose: GPR143 regulates melanosome biogenesis and organelle size in pigment cells. The mechanisms underlying receptor function remain unclear. G protein-coupled receptors (GPCRs) are excellent pharmacologic targets; thus, we developed and applied a screening approach to identify potential GPR143 ligands and chemical modulators. Methods: GPR143 interacts with ß-arrestin; we therefore established a ß-arrestin recruitment assay to screen for compounds that modulate activity. Because GPR143 is localized intracellularly, screening with the wild-type receptor would be restricted to agents absorbed by the cell. For the screen we used a mutant receptor, which shows similar basal activity as the wild type but traffics to the plasma membrane. We tested two compound libraries and investigated validated hits for their effects on melanocyte pigmentation. Results: GPR143, which showed high constitutive activity in the ß-arrestin assay, was inhibited by several compounds. The three validated inhibitors (pimozide, niclosamide, and ethacridine lactate) were assessed for impact on melanocytes. Pigmentation and expression of tyrosinase, a key melanogenic enzyme, were reduced by all compounds. Because GPR143 appears to be constitutively active, these compounds may turn off its activity. Conclusions: X-linked ocular albinism type I, characterized by developmental eye defects, results from GPR143 mutations. Identifying pharmacologic agents that modulate GPR143 activity will contribute significantly to our understanding of its function and provide novel tools with which to study GPCRs in melanocytes and retinal pigment epithelium. Pimozide, one of three GPR143 inhibitors identified in this study, maybe be a good lead structure for development of more potent compounds and provide a platform for design of novel therapeutic agents.


Asunto(s)
Albinismo Ocular/genética , Proteínas del Ojo/genética , Enfermedades Genéticas Ligadas al Cromosoma X/genética , Glicoproteínas de Membrana/genética , Mutación , ARN/genética , Albinismo Ocular/tratamiento farmacológico , Albinismo Ocular/metabolismo , Células Cultivadas , Análisis Mutacional de ADN , Etacridina/farmacología , Exones , Proteínas del Ojo/antagonistas & inhibidores , Proteínas del Ojo/metabolismo , Enfermedades Genéticas Ligadas al Cromosoma X/dietoterapia , Enfermedades Genéticas Ligadas al Cromosoma X/metabolismo , Humanos , Ligandos , Glicoproteínas de Membrana/antagonistas & inhibidores , Glicoproteínas de Membrana/metabolismo , Niclosamida/farmacología , Linaje , Pimozida/farmacología
10.
J Invest Dermatol ; 137(2): 457-465, 2017 02.
Artículo en Inglés | MEDLINE | ID: mdl-27720922

RESUMEN

Developmental eye defects in X-linked ocular albinism type 1 are caused by G-protein coupled receptor 143 (GPR143) mutations. Mutations result in dysfunctional melanosome biogenesis and macromelanosome formation in pigment cells, including melanocytes and retinal pigment epithelium. GPR143, primarily expressed in pigment cells, localizes exclusively to endolysosomal and melanosomal membranes unlike most G protein-coupled receptors, which localize to the plasma membrane. There is some debate regarding GPR143 function and elucidating the role of this receptor may be instrumental for understanding neurogenesis during eye development and for devising therapies for ocular albinism type I. Many G protein-coupled receptors require association with other proteins to function. These G protein-coupled receptor-interacting proteins also facilitate fine-tuning of receptor activity and tissue specificity. We therefore investigated potential GPR143 interaction partners, with a focus on the melanogenic enzyme tyrosinase. GPR143 coimmunoprecipitated with tyrosinase, while confocal microscopy demonstrated colocalization of the proteins. Furthermore, tyrosinase localized to the plasma membrane when coexpressed with a GPR143 trafficking mutant. The physical interaction between the proteins was confirmed using fluorescence resonance energy transfer. This interaction may be required in order for GPR143 to function as a monitor of melanosome maturation. Identifying tyrosinase as a potential GPR143 binding protein opens new avenues for investigating the mechanisms that regulate pigmentation and neurogenesis.


Asunto(s)
Albinismo Ocular/etiología , Proteínas del Ojo/fisiología , Glicoproteínas de Membrana/fisiología , Monofenol Monooxigenasa/fisiología , Animales , Células COS , Chlorocebus aethiops , Proteínas del Ojo/análisis , Proteínas del Ojo/química , Transferencia Resonante de Energía de Fluorescencia , Humanos , Glicoproteínas de Membrana/análisis , Glicoproteínas de Membrana/química , Monofenol Monooxigenasa/análisis , Monofenol Monooxigenasa/química , Neurogénesis , Pigmentación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA